5 Stocks With Recent Price Strength to Maximize Your Gains

U.S. stock markets have started 2026 on a positive note. All three major stock indexes are trading in positive territory. However, a handful of stocks have shown price strength. We have primarily targeted stocks that have recently been on a bull run. These stocks have a high chance of carrying the momentum forward.

Five such stocks are — Innovative Aerosystems Inc. ISSC, Aura Minerals Inc. AUGO, Owlet Inc. OWLT, Krystal Biotech Inc. KRYS and Intellicheck Inc. IDN.

If a stock is continuously witnessing an uptrend, there must be a solid reason or it would have probably crashed. So, looking at stocks capable of beating the benchmark that they have set for themselves seems rational.

However, recent price strength alone cannot create magic. Therefore, other relevant parameters are needed to create a successful investment strategy.

Here’s how you should create the screen to shortlist the current as well as the potential winners.

Screening Parameters:

Percentage Change in Price (4 Weeks) greater than zero: This criterion shows that the stock has moved higher in the last four weeks. 

Percentage Change Price (12 Weeks) greater than 10: This indicates that the stock has seen momentum over the last three months. This lowers the risk of choosing stocks that may have drawn attention due to the overwhelming performance of the overall market in a very short period. 

Zacks Rank 1: No matter whether market conditions are good or bad, stocks with a Zacks Rank #1 (Strong Buy) have a proven history of outperformance. You can see the complete list of today’s Zacks #1 Rank stocks here.

Average Broker Rating 1: This indicates that brokers are also highly hopeful about the stock’s future performance. 

Current Price greater than 5: The stocks must all be trading at a minimum of $5.

Current Price/ 52-Week High-Low Range more than 85%: This criterion filters stocks that are trading near their respective 52-week highs. It indicates that these are strong enough in terms of price.

Just these few criteria narrowed down the search from over 7,700 stocks to six.

Let’s discuss five out of those six stocks here:

Innovative Aerosystems designs, manufactures and sells flight avionics products, which are electronic instruments used in the operation of aircraft, to the military and government, commercial air transport and corporate aviation markets primarily to upgrade, or retrofit aircraft currently in use. 
ISSC’s products include flight information computers, electronic displays and advanced monitoring systems that measure and display critical flight information, including air data, such as airspeed and altitude, and engine and fuel data.

The stock price of ISSC has soared 76.5% over the past four weeks. It has an expected earnings growth rate of -3.6% for the current year (ending September 2026). The Zacks Consensus Estimate for current-year earnings has improved 6.7% over the last 30 days.

Aura Minerals is a company focused on the development and operation of gold and base metal projects principally in the Americas. AUGO operates through the Minosa Mine, Apoena Mine, the Aranzazu Mine, Corporate, Almas Mine, and Borborema Projects segments.

The stock price of AUGO has jumped 21.4% over the past four weeks. It has an expected earnings growth rate of more than 100% for next year. The Zacks Consensus Estimate for next year’s earnings has improved 0.1% over the last seven days.

Owlet provides a digital parenting platform that aims to give parents real-time data and insights to help them feel calmer and more confident. OWLT provides sock monitors, including Dream Sock, a wearable infant health monitor equipped with pulse oximetry technology that tracks vital signs, such as pulse rate, activity, oxygen level, and sleep patterns, 

OWLT also offers BabySat, which is intended for infants with conditions, including respiratory syncytial virus, pneumonia, bronchitis, croup, and other diagnoses, and Owlet Smart Sock, which provides real-time heart rate and oxygen readings in the Owlet Care App.

The stock price of OWLT has surged 12.7% over the past four weeks. It has an expected earnings growth rate of -122.7% for the current year. The Zacks Consensus Estimate for the current year’s earnings has improved 47.9% over the last 30 days.

Krystal Biotech’s lead drug, Vyjuvek — the first-ever gene therapy for treating patients aged six months or older with dystrophic epidermolysis bullosa — has witnessed strong uptake since its launch. The recent approval in additional geographies (the EU and Japan) should boost sales. 

Additionally, KRYS is advancing a robust pipeline of investigational genetic medicines in the fields of respiratory, oncology, dermatology, ophthalmology and aesthetics. The recent pipeline progress is encouraging and the successful development of any of these pipeline candidates will diversify the revenue stream. 

The stock price of KRYS has advanced 12% over the past four weeks. The company has expected earnings growth of 31.2% for the current year. The Zacks Consensus Estimate for the current year’s earnings has improved 1.4% over the last seven days.

Intellicheck is a leading technology company, developing and marketing wireless technology and identity systems for various applications including: mobile and handheld wireless devices for the government, military and commercial markets. Products include the Defense ID system, an advanced ID card access control product currently protecting over 70 military and federal locations. 

IDN’s ID-Check is a technology that instantly reads, analyzes, and verifies encoded data in magnetic stripes and barcodes on government-issue IDs from approximately 60 U.S. and Canadian jurisdictions to determine if the content and format are valid. 

IDN’s products are used to address government and commercial fraud, focusing on age verification, secure access control and software tools, driver's license readers, and ID validation markets. Intelli-Check Mobilisa sells its products through its direct sales force and marketing partners.

The stock price of Intellicheck has risen 2.7% over the past four weeks. The company has expected earnings growth of more than 100% for the current year. The Zacks Consensus Estimate for the current year’s earnings has improved 20% over the last 30 days.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research